Prostate Cancer Reports

Volume 6 Number 10
October 2018


Home > Prostate Cancer Reports > Volume 6, Year 2018 > Number 10, October



CONTENTS



DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
ETIOLOGY, PATHOGENESIS, PATHOLOGY
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT



DIAGNOSIS

.

Couñago F, Artigas C, Sancho G, Gómez-Iturriaga A, Gómez-Caamaño A, Maldonado A, Caballero B, López-Campos F, Recio M, Del Cerro E, Henríquez I.
Importance of 68Ga-PSMA PET/CT in hospital practice. View of the radiation oncologist.
Rev Esp Med Nucl Imagen Mol. 2018 Aug 20. pii: S2253-654X(18)30150-1. doi: 10.1016/j.remn.2018.07.005. [Epub ahead of print] English, Spanish.
Source | Abstract | Similar articles



.

Evangelista L, Zattoni F.
The war is opened: PSMA vs. 64CuCL2 vs. choline PET/CT.
J Nucl Med. 2018 Aug 16. pii: jnumed.118.218289. doi: 10.2967/jnumed.118.218289. [Epub ahead of print]
Source | Full text | Similar articles



.

Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, Agoritsas T, Dahm P.
Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis.
BMJ. 2018 Sep 5;362:k3519. doi: 10.1136/bmj.k3519.
Source | Full text | Similar articles



.

Malaspina S, De Giorgi U, Kemppainen J, Del Sole A, Paganelli G.
68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer.
Radiol Med. 2018 Aug 16. doi: 10.1007/s11547-018-0929-9. [Epub ahead of print]
Source | Full text | Similar articles



.

Möller A, Olsson H, Grönberg H, Eklund M, Aly M, Nordström T.
The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort.
Prostate Cancer Prostatic Dis. 2018 Aug 31. doi: 10.1038/s41391-018-0082-5. [Epub ahead of print]
Source | Full text | Similar articles



.

Oh SW, Cheon GJ.
Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges.
Korean J Radiol. 2018 Sep-Oct;19(5):819-831. doi: 10.3348/kjr.2018.19.5.819. Epub 2018 Aug 6.
Source | Full text | Similar articles



.

Tikkinen KAO, Dahm P, Lytvyn L, Heen AF, Vernooij RWM, Siemieniuk RAC, Wheeler R, Vaughan B, Fobuzi AC, Blanker MH, Junod N, Sommer J, Stirnemann J, Yoshimura M, Auer R, MacDonald H, Guyatt G, Vandvik PO, Agoritsas T.
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
BMJ. 2018 Sep 5;362:k3581. doi: 10.1136/bmj.k3581.
Source | Full text | Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION

.

Dall'Era MA, De Vere White RW.
New Insights into Ejaculatory Frequency and Prostate Cancer Risk: Association, Causation, or What Do We Have to Lose?
Eur Urol. 2018 Aug 31. pii: S0302-2838(18)30599-2. doi: 10.1016/j.eururo.2018.08.014. [Epub ahead of print]
Comment on: Rider JR et al, Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. (Eur Urol. 2016 Dec)
Source | Full text | Similar articles



.

You W, Henneberg M.
Prostate Cancer Incidence is Correlated to Total Meat Intake– a Cross-National Ecologic Analysis of 172 Countries
Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2229-2239.
Source | Full text | Similar articles



ETIOLOGY, PATHOGENESIS, PATHOLOGY

.

Lin CJ, Lo UG, Hsieh JT.
The regulatory pathways leading to stem-like cells underlie prostate cancer progression.
Asian J Androl. 2018 Sep 4. doi: 10.4103/aja.aja_72_18. [Epub ahead of print]
Source | Full text | Similar articles



.

Murray NP. Murray NP.
Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management.
Biol Res. 2018 Sep 4;51(1):32. doi: 10.1186/s40659-018-0180-9.
Source | Full text | Similar articles



.

Tourinho-Barbosa RR, de la Rosette J, Sanchez-Salas R.
Prostate cancer multifocality, the index lesion, and the microenvironment.
Curr Opin Urol. 2018 Aug 21. doi: 10.1097/MOU.0000000000000537. [Epub ahead of print]
Source | Fulltext | Similar articles



FOLLOW-UP, QUALITY OF LIFE

.

Vogel MME, Kessel KA, Gschwend JE, Weichert W, Wilkens JJ, Combs SE.
Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy.
Strahlenther Onkol. 2018 Sep 4. doi: 10.1007/s00066-018-1359-2. [Epub ahead of print]
Source | Full text | Similar articles



INTEGRATIVE MEDICINE

.

Allott EH, Freeman MR, Freedland SJ.
Statin Therapy to Improve Prostate Cancer Outcomes: Who, When, and for How Long?
Eur Urol. 2018 Aug 31. pii: S0302-2838(18)30597-9. doi: 10.1016/j.eururo.2018.08.012. [Epub ahead of print]
Comment on: Murtola TJ et al, Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy-A Randomized, Double-blind, Placebo-controlled Clinical Trial. (Eur Urol. 2018 Jul 18).
Source | Full text | Similar articles



.

Murtola TJ, Syvälä H, Tolonen T, Helminen M, Riikonen J, Koskimäki J, Pakarainen T, Kaipia A, Isotalo T, Kujala P, Tammela TLJ.
Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy-A Randomized, Double-blind, Placebo-controlled Clinical Trial.
Eur Urol. 2018 Jul 18. pii: S0302-2838(18)30465-2. doi: 10.1016/j.eururo.2018.06.037. [Epub ahead of print]
Source | Full text | Similar articles



OVERALL MANAGEMENT

.

Bekelman JE, Rumble RB, Chen RC, Pisansky TM, Finelli A, Feifer A, Nguyen PL, Loblaw DA, Tagawa ST, Gillessen S, Morgan TM, Liu G, Vapiwala N, Haluschak JJ, Stephenson A, Touijer K, Kungel T, Freedland SJ.
Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline.
J Clin Oncol. 2018 Sep 5:JCO1800606. doi: 10.1200/JCO.18.00606. [Epub ahead of print]
Source | Full text | Similar articles



.

Fonteyne V, Ost P.
Current Insights in the Management of High-risk Prostate Cancer: Still More Questions than Answers.
Eur Urol. 2018 Aug 30. pii: S0302-2838(18)30598-0. doi: 10.1016/j.eururo.2018.08.013. [Epub ahead of print]
Comment on: Tosco L et al, Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer. (Eur Urol. 2018 Oct 1).
Source | Full text | Similar articles



.

Mateo J, Fizazi K, Gillessen S, Heidenreich A, Perez-Lopez R, Oyen WJG, Shore N, Smith M, Sweeney C, Tombal B, Tomlins SA, de Bono JS.
Managing Nonmetastatic Castration-resistant Prostate Cancer.
Eur Urol. 2018 Aug 14. pii: S0302-2838(18)30557-8. doi: 10.1016/j.eururo.2018.07.035. [Epub ahead of print]
Source | Full text | Similar articles



.

Tosco L, Briganti A, D'amico AV, Eastham J, Eisenberger M, Gleave M, Haustermans K, Logothetis CJ, Saad F, Sweeney C, Taplin ME, Fizazi K.
Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer.
Eur Urol. 2018 Oct 1. pii: S0302-2838(18)30549-9. doi: 10.1016/j.eururo.2018.07.027. [Epub ahead of print]
Source | Full text | Similar articles



PROGNOSIS

.

Berlin A, Moraes FY, Sanmamed N, Glicksman R, Koven A, Espin-Garcia O, Leite ETT, Silva JLF, Gadia R, Nesbitt M, Catton CN, Kaffenberger S, Salami SS, Morgan TM, Hearn JWD, Jackson WC, Mehra R, Chung P, Fleshner NE, Zumsteg ZS, Dess RT, Feng FY, Finelli A, Spratt DE.
International multi-center validation of an intermediate-risk subclassification of prostate cancer treated with radical treatment without hormone therapy.
J Urol. 2018 Aug 25. pii: S0022-5347(18)43782-2. doi: 10.1016/j.juro.2018.08.044. [Epub ahead of print]
Source | Abstract | Similar articles



.

Kato M, Hirakawa A, Kobayashi Y, Yamamoto A, Ishida R, Kamihira O, Kimura T, Majima T, Ishida S, Funahashi Y, Sassa N, Fujita T, Matsukawa Y, Yamamoto T, Hattori R, Gotoh M, Tsuzuki T.
Integrating tertiary Gleason pattern 5 into the ISUP grading system improves prediction of biochemical recurrence in radical prostatectomy patients.
Mod Pathol. 2018 Sep 4. doi: 10.1038/s41379-018-0121-8. [Epub ahead of print]
Source | Full text | Similar articles



.

Liu H, Zhou H, Yan L, Ye T, Lu H, Sun X, Ye Z, Xu H.
Prognostic significance of six clinicopathological features for biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis.
Oncotarget. 2017 Nov 6;9(63):32238-32249. doi: 10.18632/oncotarget.22459. eCollection 2018 Aug 14.
Source | Full text | Similar articles



.

Ren Y, Yu GH, DU H, Wang W.
[Interval of ≤2 weeks between 12-core prostate biopsy and laparoscopic radical prostatectomy does not affect perioperative parameters or surgical outcomes].
Zhonghua Nan Ke Xue. 2018 Mar;24(3):231-235. Chinese.
Source | Abstract | Similar articles



.

Taussky D, Lambert C, Meissner N, Bahary JP, Delouya G.
Risk factors for biochemical recurrence after a tissue-ablative prostate-specific antigen <0.2 ng/mL.
Brachytherapy. 2018 Sep - Oct;17(5):794-798. doi: 10.1016/j.brachy.2018.05.011. Epub 2018 Jun 28.
Source | Fulltext | Similar articles



.

Wissing M, Brimo F, Chevalier S, Scarlata E, McKercher G, O'Flaherty A, Aprikian S, Thibodeau V, Saad F, Carmel M, Lacombe L, Têtu B, Ekindi-Ndongo N, Latour M, Trudel D, Aprikian A.
Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer.
BJU Int. 2018 Aug 16. doi: 10.1111/bju.14512. [Epub ahead of print]
Source | Full text | Similar articles



TREATMENT

.

Alpajaro SIR, Harris JAK, Evans CP.
Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapies.
Prostate Cancer Prostatic Dis. 2018 Aug 16. doi: 10.1038/s41391-018-0078-1. [Epub ahead of print]
Source | Full text | Similar articles



.

Demirel CH, Altok M, Davis JW.
Focal therapy for localized prostate cancer: is there a "middle ground" between active surveillance and definitive treatment?
Asian J Androl. 2018 Aug 31. doi: 10.4103/aja.aja_64_18. [Epub ahead of print]
Source | Full text | Similar articles



.

Narayanan R, Wilson TG.
Sentinel node evaluation in prostate cancer.
Clin Exp Metastasis. 2018 Sep 5. doi: 10.1007/s10585-018-9936-4. [Epub ahead of print]
Source | Full text | Similar articles



.

Torricelli FCM, de Carvalho PA, Guglielmetti GB, Nahas WC, Coelho RF.
Robot - assisted laparoscopic local recurrence resection after radical prostatectomy.
Int Braz J Urol. 2018 Aug 10;44. doi: 10.1590/S1677-5538.IBJU.2017.0503. [Epub ahead of print]
Source (Video) | Abstract | Similar articles



.

Zilli T, Scorsetti M, Zwahlen D, Franzese C, Förster R, Giaj-Levra N, Koutsouvelis N, Bertaut A, Zimmermann M, D'Agostino GR, Alongi F, Guckenberger M, Miralbell R.
ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial.
Radiat Oncol. 2018 Sep 4;13(1):166. doi: 10.1186/s13014-018-1112-0. Erratum in: Radiat Oncol. 2018 Sep 19;13(1):182.
Source | Full text | Similar articles